Vanda Pharmaceuticals
VNDA
#7861
Rank
C$0.44 B
Marketcap
C$7.45
Share price
3.65%
Change (1 day)
11.10%
Change (1 year)

Operating Margin for Vanda Pharmaceuticals (VNDA)

Operating Margin as of December 2025 (TTM): -57.09%

According to Vanda Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -57.09%. At the end of 2024 the company had an Operating Margin of -11.53%.

Operating Margin history for Vanda Pharmaceuticals from 2010 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-11.53%-450.43%
20233.29%-25.92%
20224.44%-71.83%
202115.77%23.61%
202012.76%-0.17%
201912.78%-2.65%
201813.12%-240.41%
2017-9.35%-23.78%
2016-12.26%-66.19%
2015-36.27%-190.11%
201440.25%-164.76%
2013-62.15%-28.93%
2012-87.44%166.86%
2011-32.77%-224.5%
201026.32%-103.34%
2009-788.46%
2004-27,867.38%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Novartis
NVS
29.12%-151.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
37.87%-166.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
18.78%-132.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
16.72%-129.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
12.60%-122.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-556,900.00% 975,377.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
31.06%-154.41%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.